Literature DB >> 2079580

Controversies in the long-term management of analgesic therapy in patients with advanced cancer.

R K Portenoy, N Coyle.   

Abstract

The management of pain in the patient with advanced cancer requires comprehensive assessment and expertise in the application of many therapeutic techniques. Given the complexity of the problems posed by these patients, it is not surprising that most aspects of palliative care derive from personal anecdote and clinical consensus, rather than well-defined guidelines based on research findings. In the absence of such guidelines, unresolved issues and controversies abound. This review discusses some of the most important of these topics, which range from the overall system of care and quality of assessment to the specifics of pharmacotherapy and other modalities of treatment. In so doing, the rationale for some of the accepted clinical approaches can be clarified, others that are as yet little known can be highlighted, and the issues most in need of further investigation can be defined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079580     DOI: 10.1016/0885-3924(90)90047-n

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  7 in total

1.  Advertisement woes.

Authors:  George Vautour
Journal:  CMAJ       Date:  2005-12-06       Impact factor: 8.262

2.  Advertisement woes.

Authors:  Saifee Rashiq
Journal:  CMAJ       Date:  2005-12-06       Impact factor: 8.262

3.  Assessment of pain and analgesic use in African American cancer patients: factors related to adherence to analgesics.

Authors:  Young O Rhee; Eugenia Kim; Bryant Kim
Journal:  J Immigr Minor Health       Date:  2012-12

Review 4.  Morphine in cancer pain: modes of administration. Expert Working Group of the European Association for Palliative Care.

Authors: 
Journal:  BMJ       Date:  1996-03-30

Review 5.  Ethical dilemmas in hospice and palliative care.

Authors:  B M Kinzbrunner
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

Review 6.  New developments in the assessment of pain in cancer patients.

Authors:  E Bruera; S Watanabe
Journal:  Support Care Cancer       Date:  1994-09       Impact factor: 3.603

Review 7.  Levorphanol: revisiting an underutilized analgesic.

Authors:  Eric Prommer
Journal:  Palliat Care       Date:  2014-05-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.